However, we dont yet have studies available that directly compare the two versions
The only exception was topiramate, which exhibited higher reporting of vision impairment than semaglutide (rOR 0.30, 95% CI 0.200.45)
, risponde alle domande pi frequenti sullutilizzo del farmaco per la cura dellobesit
however, this study adds to the growing evidence of a multi-pronged combination approach addressing obesity as a long-term condition
Different GLP-1 receptor agonists have varying pharmacokinetic profiles and receptor binding characteristics
Your dose of OZEMPIC and other diabetes medicines may need to change because of: change in level of physical activity or exercise, weight gain or loss, increased stress, illness, change in diet, fever, trauma, infection, surgery or because of other medicines you take